FREE CASE EVALUATION: 1-800-632-1404
A Xarelto lawsuit filed by an 87-year-old man claims that he experienced life-threatening internal bleeding caused by the blood thinner. The litigation filed in a California northern district federal court in October 2014 cites gastrointestinal hemorrhage as one of the blood thinner side effects. The plaintiff was treated with the anticoagulant drug for some months until October 2014, when he suffered from uncontrolled hemorrhage in the absence of any antidote to the drug, the Xarelto attorney representing the man claims.
The litigation followed a similar Xarelto internal bleeding lawsuit filed by a California woman in August 2014. Shirley Boynton began using the blood thinner in April 2012. She had life-threatening bleeding within six months that resulted in debilitating and permanent injuries. Had she been aware of such potential side effects or read about hemorrhaging risk on its label, the plaintiff would have avoided it, according to her Xarelto lawsuit filed in a New York district court.
The two lawsuits have named Bayer and Johnson and Johnson as defendants and seek $10 million in damages.
Xarelto Lawsuit: Blood Thinner Side Effects Research
The FDA approved Bayer’s oral anticoagulant Xarelto, which contains rivaroxaban, in July 2011. Marketed by Janssen, the drug is prescribed to people with knee surgery or others at the higher risk of blood clotting. It inhibits factor Xa, which in turn “interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade.” In November 2011, the drug was allowed to treat patients suffering from atrial fibrillation or clots in blood arteries, a possible indication of stroke.
However, researchers have questioned the efficacy of the drug advertised by the manufacturers. Though the impact is slated to last 8 to 12 hours, the anticougaltion properties in the body continue to remain subdued for 24 hours. The absence of any readily available antidote makes the Xarelto blood thinner even more dangerous and may lead to excessive, life-threatening bleeding, as cited by many product liability lawsuits.
According to the American Heart Association, Xarelto is likely to cause the three-time higher risk of internal bleeding acute ill patients. The risk is four-time more in those with preexisting Acute Coronary Syndrome, asserts one of its reports presented in November 2013.
The German newsmagazine Der Spiegel carried a report in 2013 that linked Xarelto blood thinner to 72 deaths and 896 hemorrhage events between January and October 2013. The figures for 2012 were 58 deaths and 692 internal bleeding complaints.
A comparative study by Johnson & Johnson conducted in April 2011 discovered that patients treated with oral anticoagulant Xarelto for more than 35 days twice more prone to developing bleeding adverse events compared to Lovenox, an injectable blood thinner with enoxaparin as the main ingredient.
The ROCKET AF clinical trial results reported the Journal of the American College of Cardiology in December 2013 also demonstrated bleeding or hemorrhage as the most common Xarelto side effect. Funded by the manufacturers, the study covered 14,000 patients treated with Xarelto and Warfarin blood thinners over a two-year period. While both drugs were found to cause identical side effects, Xarelto was not superior to Warfarin, the researchers concluded.
It was also discovered that Xarelto-induced hemorrhage has less impact in the brain, but had significant bleeding rate for stomach and intestine.
Xarelto Blood Thinner Side Effects
- Cerebral hemorrhage
- Gastrointestinal bleeding
- Stroke
- Wrongful death
- Stomach and adrenal bleeding
- Subarachnoid, subdural, and extradural hemorrhages
- Swelling leads to intracranial hematoma in brain
Xarelto Lawsuit
A motion was filed early October 2014 to centralize all Xarelto hemorrhage lawsuits filed in different states. At that time about two dozen such litigations citing bleeding injuries were pending at the federal judicial system spread over 10 states. The plaintiffs have sought MDL pretrial consolidation at the Southern District Court of Illinois presided by David R. Herndon. The U.S. JPML planned to meet in Charleston, SC, on December 4 or in Miami, FL, on January 29 is expected to take a look at consolidation.
Meanwhile, there has been a noticeable increase in the filing of Xarelto lawsuits claiming wrongful death, fatal and non-fatal internal bleeding, coma, cerebral hemorrhage, and other types of injuries. The actual litigation numbers may run in hundreds as many affected individuals contacting Xarelto lawyers to examine the product liability claims.
For a free consultation with our experienced Xarelto attorneys, please contact us or call on 1-800-632-1404.
Contact a Xarelto Injury Lawyer Today.
If you or a loved one was injured or died after ingesting Xarelto, please contact us immediately.
For a Free Case Evaluation:
TOLL FREE: 1-800-632-1404
EMAIL: click here
FILL OUT THIS FORM:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.
One Reply to “Xarelto Lawsuit: Plaintiffs Allege Life-Threatening Bleeding Linked to Blood Thinner”